Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217867 · ClinicalTrials.gov registry record · NA
Educational and Supportive Interventions to Prevent Cardiopulmonary Rehospitalization
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 832
- Enrollment target
NCT00217867: Completed NA study, sponsored by Boston Medical Center.
NCT00217867 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 832 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217867, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 832 participants
- Enrollment target
Study Summary
This study will use a comprehensive hospital discharge toolkit to implement up-to-date guidelines for cardiopulmonary diseases. The study will also include a computer-based patient-education program and a telephone-based post-discharge program, both designed for individuals with limited health literacy. The purpose of this study is to reduce early hospital readmission.
Interventions
- BEHAVIORAL Animated character intervention with telephone follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 832 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT00217867 record still lists
NCT00217867 is an interventional study that assigns participants to a tested intervention. The registered 832 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 1 intervention - of which Animated character intervention with telephone follow-up is the first listed.
NCT00217867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00217867 about?
NCT00217867 is a clinical study titled "Educational and Supportive Interventions to Prevent Cardiopulmonary Rehospitalization". This study will use a comprehensive hospital discharge toolkit to implement up-to-date guidelines for cardiopulmonary diseases. The study will also include a computer-based patient-education program and a telephone-based post-discharge program, both designed for individuals with limited health liter...
What is the current status of trial NCT00217867?
This trial is currently completed. It is a NA study. The enrollment target is 832 participants. The study started on 2008-10. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00217867?
The interventions under investigation include: Animated character intervention with telephone follow-up (BEHAVIORAL).
Who is sponsoring clinical trial NCT00217867?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00217867's enrollment target sits among peer trials
832 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia